Immunotherapy has emerged as a promising cancer treatment modality. Despite the rapid
progress in cancer immunotherapy, the therapeutic efficiency and clinical translation of …

Nanomaterial-synergized photodynamic therapy (PDT) and photothermal therapy (PTT), as
efficient and non-invasive treatment modalities, have shown significant advantages in …

Packaging multiple drugs into a nanocarrier with rational design to achieve synergistic
cancer therapy remains a challenge due to the intrinsically varied pharmacodynamics of …

Induction of immunogenic cell death (ICD) in tumor combined with immune checkpoint
blockade (ICB) therapy is widely developed to improve the efficacy of cancer …

Innovative anticancer therapies based on the activation of the immune system offer promise
in the battle against cancers resistant to traditional treatments. Examples of such therapeutic …

Nanoparticulate drug delivery systems (Nano-DDSs) have emerged as possible solution to
the obstacles of anticancer drug delivery. However, the clinical outcomes and translation are …

The checkpoint inhibitor therapy that blocks programmed death‐1 (PD‐1) and its major
ligand PD‐L1 has achieved encouraging clinical efficacy in certain cancers. However, the …

Photodynamic therapy (PDT) is commonly used as an “in situ vaccine” to enhance the
response rate of PD‐1/PD‐L1 antibodies. Unfortunately, the high cost and adverse effects of …

The recently developed reactive oxygen species (ROS)-manipulated nanocatalytic medicine
in cancer treatment based on the Fenton reaction, defined as chemodynamic therapy (CDT) …

Photodynamic therapy (PDT) and chemotherapy show clinical promise in destroying
orthotopic tumors but are insufficient against abscopal metastases. The research reports the …